Evaluation of Commercially Available Anti–Dengue Virus Immunoglobulin M Tests

Evaluation of Commercially Available Anti–Dengue Virus Immunoglobulin M Tests

Anti–dengue virus immunoglobulin M kits were evaluated. Test sensitivities were 21%–99% and specificities were 77%–98% compared with reference ELISAs. False-positive results were found for patients with malaria or past dengue infections. Three ELISAs showing strong agreement with reference ELISAs wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Elizabeth A. Hunsperger, Sutee Yoksan, Philippe Buchy, Vinh Chau Nguyen, Shamala D. Sekaran, Delia A. Enria, Jose L. Pelegrino, Susana Vázquez, Harvey Artsob, Michael Drebot, Duane J. Gubler, Scott B. Halstead, María G. Guzmán, Harold S. Margolis, Carl-Michael Nathanson, Nidia R. Rizzo Lic, Kovi E. Bessoff, Srisakul Kliks, Rosanna W. Peeling
Formato: Artículo
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2009-03-01
Colección:Emerging Infectious Diseases
Materias:
Dengue fever
immunoglobulin M
ELISA
diagnostic test
dispatch
Thailand
Acceso en línea:https://wwwnc.cdc.gov/eid/article/15/3/08-0923_article

Internet

https://wwwnc.cdc.gov/eid/article/15/3/08-0923_article

Ejemplares similares